[1]
|
Wang, G., Zhao, G., Chao, X., et al. (2020) The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. International Journal of Environmental Research and Public Health, 17, 6278-6295.
https://doi.org/10.3390/ijerph17176278
|
[2]
|
Fu, B., Yin, D., Sun, C., et al. (2022) Clonal and Horizontal Trans-mission of blaNDM among Klebsiella pneumoniae in Children’s Intensive Care Units. Microbiology Spectrum, 10, e0157421.
|
[3]
|
Vergadi, E., Bitsori, M., Maraki, S., et al. (2017) Community-Onset Carbapenem-Resistant Klebsiella pneumoniae Urinary Tract Infections in Infancy Following NICU Hospitalisation. Journal of Pediatric Urology, 13, 495e491- 495e496. https://doi.org/10.1016/j.jpurol.2017.02.008
|
[4]
|
Shao, C., Wang, W., Liu, S., et al. (2021) Molecular Epidemiology and Drug Resistant Mechanism of Carbapenem- Resistant Klebsiella pneumoniae in Elderly Pa-tients with Lower Respiratory Tract Infection. Frontiers in Public Health, 9, 669173-669183. https://doi.org/10.3389/fpubh.2021.669173
|
[5]
|
Fritzenwanker, M., Imirzalioglu, C., Herold, S., et al. (2018) Treatment Options for Carbapenem-Resistant Gram- Negative Infections. Deutsches Ärzteblatt International, 115, 345-352. https://doi.org/10.3238/arztebl.2018.0345
|
[6]
|
Zhen, X., Stalsby Lundborg, C., Sun, X., et al. (2020) Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China. Antibiotics (Basel), 9, 514-527. https://doi.org/10.3390/antibiotics9080514
|
[7]
|
Zhu, Y., Xiao, T., Wang, Y., et al. (2021) Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem- Resistant Enterobacteriaceae. Infection and Drug Resistance, 14, 5385-5393. https://doi.org/10.2147/IDR.S341664
|
[8]
|
MacKenzie, F.M., Forbes, K.J., Dorai-John, T., et al. (1997) Emergence of a Carbapenem-Resistant Klebsiella pneumoniae. The Lancet, 350, 783. https://doi.org/10.1016/S0140-6736(05)62567-6
|
[9]
|
Yigit, H., Queenan, A.M., Anderson, G.J., et al. (2001) Novel Carbapenem-Hydrolyzing Beta-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 1151- 1161. https://doi.org/10.1128/AAC.45.4.1151-1161.2001
|
[10]
|
Yong, D., Toleman, M.A., Giske, C.G., et al. (2009) Characterization of a New Metallo-Beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrobial Agents and Chem-otherapy, 53, 5046-5054.
https://doi.org/10.1128/AAC.00774-09
|
[11]
|
王珊珊, 赵建平. 2014-2018年耐碳青霉烯类肺炎克雷伯菌分离及耐药率分析[J]. 中国抗生素杂志, 2020, 45(10): 1058-1062.
|
[12]
|
周馨, 马筱玲, 戴媛媛, 等. 2014-2017年某院肺炎克雷伯菌分布及耐药性分析[J]. 中华医院感染学杂志, 2019, 29(21): 3210-3215.
|
[13]
|
杨程茹, 王英, 李莹, 等. 重症监护病房耐碳青霉烯类肺炎克雷伯菌分子流行病学研究[J]. 中国感染控制杂志, 2022, 21(3): 209-216.
|
[14]
|
南超, 黄一凤, 马娜, 等. ICU患者耐碳青霉烯类肺炎克雷伯菌的耐药及传播机制的分析[J]. 中国病原生物学杂志, 2022, 17(5): 578-581.
|
[15]
|
郑军涛, 胡会. 耐碳青霉烯类肺炎克雷伯菌的基因组分型及耐药性评估[J]. 中国药物滥用防治杂志, 2022, 28(4): 528-531.
|
[16]
|
王群, 王亦晨, 张祎博, 等. 2016-2020年某三级综合医院耐碳青霉烯类肺炎克雷伯菌检出趋势[J]. 中华医院感染学杂志, 2022, 32(6): 835-839.
|
[17]
|
Zhang, H., Wang, J., Zhou, W., et al. (2021) Risk Factors and Prognosis of Carbapenem-Resistant Klebsiella pneumoniae Infections in Respiratory In-tensive Care Unit: A Retrospective Study. Infection and Drug Resistance, 14, 3297- 3305. https://doi.org/10.2147/IDR.S317233
|
[18]
|
Liu, L., Feng, Y., Wei, L., et al. (2021) KPC-2-Producing Car-bapenem-Resistant Klebsiella pneumoniae of the Uncommon ST29 Type Carrying OXA-926, a Novel Narrow-Spectrum OXA beta-Lactamase. Frontiers in Microbiology, 12, Article ID: 701513. https://doi.org/10.3389/fmicb.2021.701513
|
[19]
|
Chang, A.H., Sharma, L., Dela Cruz, C.S., et al. (2021) Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Frontiers in Microbiology, 12, Article ID: 750662.
https://doi.org/10.3389/fmicb.2021.750662
|
[20]
|
贺宇, 姚卫, 卿克勤, 等. 耐碳青霉烯类肺炎克雷伯菌的分布特征及耐药性分析[J]. 基因组学与应用生物学, 2021, 40(Z3): 3296-3301.
|
[21]
|
胡小品, 袁国航, 吴瑶瑶, 等. 中国西南地区3所综合性医院耐碳青霉烯类肺炎克雷伯菌流行病学特征及耐药性[J]. 中国感染控制杂志, 2022, 21(2): 121-127.
|
[22]
|
黄静敏, 柯碧霞, 何冬梅, 等. 广东地区耐碳青霉烯类肺炎克雷伯菌耐药性及分子流行病学特征[J]. 中华医院感染学杂志, 2022, 32(6): 813-818.
|
[23]
|
Toledano-Tableros, J.E., Gayosso-Vazquez, C., Jaril-lo-Quijada, M.D., et al. (2021) Dissemination of bla NDM-1 Gene among Several Klebsiella pneumoniae Sequence Types in Mexico Associated with Horizontal Transfer Mediated by IncF-Like Plasmids. Frontiers in Microbiology, 12, 611274-611283. https://doi.org/10.3389/fmicb.2021.611274
|
[24]
|
Li, T., Wang, Q., Chen, F., et al. (2013) Bio-chemical Characteristics of New Delhi Metallo-Beta-Lactamase-1 Show Unexpected Difference to Other MBLs. PLOS ONE, 8, e61914-61919. https://doi.org/10.1371/journal.pone.0061914
|
[25]
|
Shein, A.M.S., Wannigama, D.L., Hig-gins, P.G., et al. (2021) Novel colistin-EDTA Combination for Successful Eradication of Colistin-Resistant Klebsiella pneumoniae Catheter-Related Biofilm Infections. Scientific Reports, 11, 21676- 21689. https://doi.org/10.1038/s41598-021-01052-5
|
[26]
|
Poirel, L., Heritier, C., Tolun, V., et al. (2004) Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 48, 15-22.
https://doi.org/10.1128/AAC.48.1.15-22.2004
|
[27]
|
Lee, C.R., Lee, J.H., Park, K.S., et al. (2016) Global Dissemi-nation of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Frontiers in Microbiology, 7, 895-925.
https://doi.org/10.3389/fmicb.2016.00895
|
[28]
|
Duman, Y., Ersoy, Y., Gursoy, N.C., et al. (2020) A Silent Out-break Due to Klebsiella pneumoniae That Co-Produced NDM-1 and OXA-48 Carbapenemases, and Infection Control Measures. Iranian Journal of Basic Medical Sciences, 23, 46-50.
|
[29]
|
Del Rio, A., Muresu, N., Sotgiu, G., et al. (2022) High-Risk Clone of Klebsiella pneumoniae Co-Harbouring Class A and D Carbapenemases in Italy. International Jour-nal of Environmental Research and Public Health, 19, 2623-2634.
https://doi.org/10.3390/ijerph19052623
|
[30]
|
Han, X., Chen, Y., Zhou, J., et al. (2022) Epidemiological Character-istics of OXA-232-Producing Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated during Nosocomial Clonal Spread Associated with Environmental Colonization. Microbiology Spectrum, 2022, e0257221. https://doi.org/10.1128/spectrum.02572-21
|
[31]
|
Nishimura, F., Morinaga, Y., Akamatsu, N., et al. (2018) Plas-mid-Mediated AmpC beta-Lactamase and Underestimation of Extended-Spectrum beta-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates. Japanese Journal of Infectious Diseases, 71, 281-285. https://doi.org/10.7883/yoken.JJID.2017.469
|
[32]
|
Cruz-Lopez, F., Martinez-Melendez, A., Morfin-Otero, R., et al. (2022) Efficacy and in Vitro Activity of Novel Antibiotics for Infections with Car-bapenem-Resistant Gram-Negative Pathogens. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 884365. https://doi.org/10.3389/fcimb.2022.884365
|
[33]
|
Bassetti, M., Giacobbe, D.R., Castaldo, N., et al. (2021) Role of New Antibiotics in Extended-Spectrum Beta-Lactamase-, AmpC-Infections. Current Opinion in Infectious Diseases, 34, 748-755.
https://doi.org/10.1097/QCO.0000000000000789
|
[34]
|
Shi, W., Li, K., Ji, Y., et al. (2013) Carbapenem and Cefox-itin Resistance of Klebsiella pneumoniae Strains Associated with Porin OmpK36 Loss and DHA-1 Beta-Lactamase Pro-duction. Brazilian Journal of Microbiology, 44, 435-442.
https://doi.org/10.1590/S1517-83822013000200015
|
[35]
|
Le, T., Wang, L., Zeng, C., et al. (2021) Clinical and Mi-crobiological Characteristics of Nosocomial, Healthcare-Asso- ciated, and Community-Acquired Klebsiella pneumoniae Infections in Guangzhou, China. Antimicrobial Resistance & Infection Control, 10, 41-52. https://doi.org/10.1186/s13756-021-00910-1
|
[36]
|
Cao, X., Zhong, Q., Guo, Y., et al. (2021) Emergence of the Coexistence of mcr-1, bla NDM-5, and bla CTX-M-55 in Klebsiella pneumoniae ST485 Clinical Isolates in China. Infec-tion and Drug Resistance, 14, 3449-3458.
https://doi.org/10.2147/IDR.S311808
|
[37]
|
Ejaz, H. (2022) Analysis of Diverse beta-lactamases Presenting High-Level Resistance in Association with OmpK35 and OmpK36 Porins in ESBL-Producing Klebsiella pneumoniae. Saudi Journal of Biological Sciences, 29, 3440-3447.
https://doi.org/10.1016/j.sjbs.2022.02.036
|
[38]
|
Sharma, A., Gupta, V.K., and Pathania, R. (2019) Efflux Pump In-hibitors for Bacterial Pathogens: From Bench to Bedside. Indian Journal of Medical Research, 149, 129-145. https://doi.org/10.4103/ijmr.IJMR_2079_17
|
[39]
|
Zhang, Q., Lin, L., Pan, Y., et al. (2021) Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates from a Chinese Tertiary Care Teaching Hospital. Frontiers in Microbiology, 12, 671153-671165.
https://doi.org/10.3389/fmicb.2021.671153
|
[40]
|
Sutaria, D.S., Moya, B., Green, K.B., et al. (2018) First Penicil-lin-Binding Protein Occupancy Patterns of Beta-Lactams and beta-Lactamase Inhibitors in Klebsiella pneumoniae. Anti-microbial Agents and Chemotherapy, 62, e00282-18.
https://doi.org/10.1128/AAC.00282-18
|